Stocks › PCVX
Vaxcyte, Inc.
PCVX·Nasdaq·
United States·USD
United States·USD$66.70
-7.12 (-9.65%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
PCVX
Vaxcyte, Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
PCVXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of PCVX by members of U.S. Congress · 9 on record · 3 in the last 12 months
Whale Activity
Position changes in PCVX reported for 2026-06-30 by 10 tracked institutional filers
- Increased5
- New0
- Held0
- Decreased3
- Closed1
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock, Inc. | 12.1M | $701.5M | increased |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.6M | $383.3M | increased |
| VANGUARD CAPITAL MANAGEMENT LLC | 6.3M | $369.0M | increased |
| D. E. Shaw & Co., Inc. | 1.9M | $110.6M | decreased |
| TWO SIGMA INVESTMENTS, LP | 273.9K | $15.9M | increased |
| MILLENNIUM MANAGEMENT LLC | 136.6K | $7.9M | decreased |
| Bridgewater Associates, LP | 50.2K | $2.9M | increased |
| Seven Fleet Capital Management LP | 29.8K | $1.8M | — |
| RENAISSANCE TECHNOLOGIES LLC | 19.6K | $1.1M | decreased |
| Point72 Asset Management | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by PCVX insiders, by quarter · Form 4
Recent Insider Transactions
906 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Wassil JimEVP, Chief Scientific Ofc, COO | Sale | −95 | $57.09 | $5K | Oct 1, 2026 | Form 4 ↗ |
| Wassil JimEVP, Chief Scientific Ofc, COO | Sale | −2,155 | $56.65 | $122K | Oct 1, 2026 | Form 4 ↗ |
| Wassil JimEVP, Chief Scientific Ofc, COO | Sale | −1,334 | $59.52 | $79K | Sep 9, 2026 | Form 4 ↗ |
| Wassil JimEVP, Chief Scientific Ofc, COO | Sale | −1,381 | $61.16 | $84K | Sep 4, 2026 | Form 4 ↗ |
| Wassil JimCHIEF OPERATING OFFICER | Sale | −924 | $60.95 | $56K | Sep 1, 2026 | Form 4 ↗ |
| Wassil JimCHIEF OPERATING OFFICER | Sale | −713 | $61.48 | $44K | Sep 1, 2026 | Form 4 ↗ |
| Wassil JimCHIEF OPERATING OFFICER | Sale | −303 | $61.42 | $19K | Sep 1, 2026 | Form 4 ↗ |
| Wassil JimCHIEF OPERATING OFFICER | Sale | −1,537 | $60.89 | $94K | Sep 1, 2026 | Form 4 ↗ |
| Dhaliwal Harpreet S.Chief Technical Ops Officer | Sale | −17.0K | $55.00 | $935K | Aug 5, 2026 | Form 4 ↗ |
| Wassil JimCHIEF OPERATING OFFICER | Sale | −861 | $53.50 | $46K | Aug 3, 2026 | Form 4 ↗ |
| Wassil JimCHIEF OPERATING OFFICER | Sale | −1,389 | $54.09 | $75K | Aug 3, 2026 | Form 4 ↗ |
| GUGGENHIME ANDREWPRESIDENT AND CFO | Sale | −6,956 | $53.76 | $374K | Aug 3, 2026 | Form 4 ↗ |
| GUGGENHIME ANDREWPRESIDENT AND CFO | Sale | −3,044 | $54.18 | $165K | Aug 3, 2026 | Form 4 ↗ |
| PICKERING GRANTCHIEF EXECUTIVE OFFICER · Director | Sale | −756 | $55.52 | $42K | Jul 27, 2026 | Form 4 ↗ |
| PICKERING GRANTCHIEF EXECUTIVE OFFICER · Director | Sale | −622 | $55.54 | $35K | Jul 27, 2026 | Form 4 ↗ |
| PICKERING GRANTCHIEF EXECUTIVE OFFICER · Director | Sale | −4,415 | $55.93 | $247K | Jul 27, 2026 | Form 4 ↗ |
| PICKERING GRANTCHIEF EXECUTIVE OFFICER · Director | Sale | −378 | $55.91 | $21K | Jul 27, 2026 | Form 4 ↗ |
| PICKERING GRANTCHIEF EXECUTIVE OFFICER · Director | Sale | −244 | $55.96 | $14K | Jul 27, 2026 | Form 4 ↗ |
| PICKERING GRANTCHIEF EXECUTIVE OFFICER · Director | Sale | −11.8K | $55.52 | $654K | Jul 27, 2026 | Form 4 ↗ |
| GUGGENHIME ANDREWPRESIDENT AND CFO | Sale | −7,913 | $57.16 | $452K | Jul 6, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding PCVX · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4.6M | $266.7M | 0.01% | Jun 30, 2026 |
| T. Rowe Price Capital Appreciation Fund T. ROWE PRICE CAPITAL APPRECIATION FUND, INC. | 4.0M | $232.9M | 0.33% | Jun 30, 2026 |
| iShares Russell 2000 ETF iShares Trust | 3.4M | $197.2M | 0.24% | Jun 30, 2026 |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 3.3M | $192.6M | 0.10% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund Fidelity Rutland Square Trust II | 3.0M | $156.0M | 0.06% | May 31, 2026 |
| Janus Henderson Forty Fund Janus Investment Fund | 2.7M | $155.6M | 0.65% | Jun 30, 2026 |
| Janus Henderson Enterprise Fund Janus Investment Fund | 2.3M | $131.9M | 0.59% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 2.2M | $127.4M | 1.19% | Jun 30, 2026 |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 2.3M | $126.6M | 0.33% | Jul 31, 2026 |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1.9M | $111.1M | 0.24% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list PCVX's shares (CUSIP 92243G108), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- JANUS HENDERSON GROUP Ltd.SCHEDULE 13G/A · passive (13G) · 18.0M shares12.1%
Aug 11, 2026 · ↗ - JANUS HENDERSON GROUP Ltd.SCHEDULE 13G/A · passive (13G) · 65.7K shares0.1%
Aug 7, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 20.8M shares14.4%
Aug 6, 2026 · ↗ - FMR LLCSCHEDULE 13G/A · passive (13G) · 20.8M shares14.4%
Aug 6, 2026 · ↗ - RA Capital Healthcare Fund, L.P.SCHEDULE 13G/A · passive (13G) · 12.7M shares8.7%
May 15, 2026 · ↗ - Rajeev ShahSCHEDULE 13G/A · passive (13G) · 13.0M shares8.9%
May 15, 2026 · ↗ - Peter KolchinskySCHEDULE 13G/A · passive (13G) · 13.0M shares8.9%
May 15, 2026 · ↗ - RA Capital Management, L.P.SCHEDULE 13G/A · passive (13G) · 13.0M shares8.9%
May 15, 2026 · ↗ - JANUS HENDERSON GROUP PLCSCHEDULE 13G/A · passive (13G) · 16.6M shares11.5%
May 15, 2026 · ↗ - Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 16.5M shares11.4%
May 6, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming vaxcyte as client
- BGR GOVERNMENT AFFAIRSVAXCYTE, INC. · 2026 Q2 · HCR$80K
Filing ↗ - DCI GROUP, L.L.C.VAXCYTE, INC. · 2026 Q2 · HCR$75K
Filing ↗ - BGR GOVERNMENT AFFAIRSVAXCYTE, INC. · 2026 Q1 · HCR$80K
Filing ↗ - DCI GROUP, L.L.C.VAXCYTE, INC. · 2026 Q1 · HCR$75K
Filing ↗ - BGR GOVERNMENT AFFAIRSVAXCYTE, INC. · 2025 Q4 · HCR$90K
Filing ↗
Government Contracts
Federal awards to Vaxcyte, Inc. · USAspending
No federal contract awards found for Vaxcyte, Inc..
U.S. Patents
Recent USPTO applications naming Vaxcyte, Inc.
No USPTO patent applications found for Vaxcyte, Inc..
Annual Financials
From PCVX's 10-K filings · XBRL
No annual XBRL figures on record for PCVX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in PCVX's price history.
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsOct 5, 2026
EDGAR ↗ - 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureSep 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsAug 5, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeJul 15, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeJun 23, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteJun 16, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsMay 6, 2026
EDGAR ↗
About Vaxcyte, Inc.
From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersSAN CARLOS, CA
IncorporatedDE
SEC CIK0001649094 ↗
Former namesSutroVax, Inc.